G. A. LePage
About
In The Last Decade
G. A. LePage
105 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.7k
- Epidemiology 418
- Physiology 373
- Infectious Diseases 352
- Organic Chemistry 324
Countries citing papers authored by G. A. LePage
This map shows the geographic impact of G. A. LePage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. A. LePage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. A. LePage more than expected).
Fields of papers citing papers by G. A. LePage
This network shows the impact of papers produced by G. A. LePage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. A. LePage. The network helps show where G. A. LePage may publish in the future.
Co-authorship network of co-authors of G. A. LePage
This figure shows the co-authorship network connecting the top 25 collaborators of G. A. LePage. A scholar is included among the top collaborators of G. A. LePage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. A. LePage. G. A. LePage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 1 | |
| 3 | 9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans. | 29 |
| 4 | Inhibition of DNA chain growth by alpha-2'-deoxythioguanosine. | 2 |
| 5 | Studies on the growth inhibition and metabolism of 2'-deoxy-2'-fluorocytidine in cultured human lymphoblasts. | 8 |
| 6 | Scheduling of arabinosylcytosine and 6-thioguanine therapy. | 9 |
| 7 | Studies on beta-D-xylofuranosyl-6-thioguanine in mice. | 3 |
| 8 | Some Inhibitors of Deamination of 9-β-d-Arabinofuranosyladenine and 9-β-d-Xylofuranosyladenine by Blood and Neoplasms of Experimental Animals and Humans | 30 |
| 9 | 68 | |
| 10 | 4 | |
| 11 | METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES. | 49 |
| 12 | METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO. | 6 |
| 13 | Biochemical Studies of Resistance to 6-Thioguanine | 20 |
| 14 | Use of nucleosides in resistance to 6-thioguanine. | 22 |
| 15 | The metabolism of 9-butyl-6-thioguanine in normal and neoplastic tissues. | 3 |
| 16 | Purine Metabolism in Mouse Ascites Tumor Cells | 9 |
| 17 | Metabolic effects of 6-thioguanine. II. Biosynthesis of nucleic acid purines in vivo and in vitro. | 39 |
| 18 | Purine metabolism in mouse ascites tumor cells. II. In vitro incorporation of performed purines into nucleotides and polynucleotides. | 16 |
| 19 | Purine biosynthesis and inhibitors in ascites cell tumors. | 36 |
| 20 | Aerobic glycolysis in homogenates of normal and tumor tissues. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.